Modular Medical (MODD) Stock Price, News & Analysis

Company Overview

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

Key Stats

• Today's Range: $0.80 to $0.89
• 50-Day Range: $0.75 to $1.45
• 52-Week Range: $0.68 to $2.65
• Volume: 85,172 shs
• Average Volume: 202,400 shs
• Market Capitalization: $35.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.00
• Consensus Rating: Buy

Modular Medical Stock Analysis - MarketRank™

Modular Medical scored higher than 47% of companies evaluated by MarketBeat, and ranked 574th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Modular Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Modular Medical has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Modular Medical is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Modular Medical is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Modular Medical has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.80% of the float of Modular Medical has been sold short.

Short Interest Ratio / Days to Cover

Modular Medical has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Modular Medical has recently decreased by 6.13%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Modular Medical does not currently pay a dividend.

Dividend Growth

Modular Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.80% of the float of Modular Medical has been sold short.

Short Interest Ratio / Days to Cover

Modular Medical has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Modular Medical has recently decreased by 6.13%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

2 people have searched for MODD on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Modular Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.46% of the stock of Modular Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 27.47% of the stock of Modular Medical is held by institutions.

MODD Stock Analysis - Frequently Asked Questions

How have MODD shares performed this year?

Modular Medical's stock was trading at $1.37 at the start of the year. Since then, MODD stock has decreased by 35.9% and is now trading at $0.8776.
View the best growth stocks for 2025 here.

How were Modular Medical's earnings last quarter?

Modular Medical, Inc. (NASDAQ:MODD) released its quarterly earnings data on Thursday, February, 13th. The company reported ($0.13) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01.

When did Modular Medical IPO?

Modular Medical (MODD) raised $15 million in an initial public offering on Thursday, February 10th 2022. The company issued 2,500,000 shares at a price of $6.00 per share. Oppenheimer & Co. served as the underwriter for the IPO and The Benchmark Company and Lake Street were co-managers.

Who are Modular Medical's major shareholders?

Top institutional shareholders of Modular Medical include Solas Capital Management LLC (6.10%), Bard Associates Inc. (5.29%), 683 Capital Management LLC (3.93%) and Silverarc Capital Management LLC (3.13%). Insiders that own company stock include Manchester Management Co Llc, Philip Brent Sheibley and Paul Diperna.
View institutional ownership trends.

How do I buy shares of Modular Medical?

Shares of MODD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Modular Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Modular Medical investors own include MSP Recovery (LIFW), MSP Recovery (LIFW), Top KingWin (TCJH), Top KingWin (TCJH), AutoZone (AZO), Intel (INTC) and TJX Companies (TJX).

Company Calendar

• Last Earnings: 2/13/2025
• Today: 3/09/2025
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:MODD
• CIK: 1074871
• Web: modular-medical.com
• Phone: (858) 800-3500
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $5.00
• High Stock Price Target: $5.00
• Low Stock Price Target: $5.00
• Potential Upside/Downside: +469.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.53)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-17,470,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -197.97%
• Return on Assets: -162.31%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.30
• Quick Ratio: 5.30

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.25 per share
• Price / Book: 3.51

Miscellaneous

• Outstanding Shares: 40,665,000
• Free Float: 32,345,000
• Market Cap: $35.69 million
• Optionable: Not Optionable
• Beta: 0.59